1.
Niswander LM, Loftus JP, Lainey Élodie, Caye-Eude A, Pondrom M, Hottman DA, Iacobucci I, Mullighan CG, Jain N, Konopleva M, Cavé H, Baruchel A, Rohrlich PS, Tasian SK. Therapeutic potential of ruxolitinib and ponatinib in patients with <i>EPOR</i&gt;-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia. haematol [Internet]. 2021Oct.1 [cited 2024Mar.29];106(10):2763-7. Available from: https://haematologica.org/article/view/haematol.2021.278697